Quotient Wealth Partners LLC Has $227,000 Stock Holdings in HCA Healthcare, Inc. (NYSE:HCA)

Quotient Wealth Partners LLC decreased its stake in HCA Healthcare, Inc. (NYSE:HCA) by 12.2% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 755 shares of the company’s stock after selling 105 shares during the quarter. Quotient Wealth Partners LLC’s holdings in HCA Healthcare were worth $227,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors also recently made changes to their positions in HCA. MML Investors Services LLC grew its stake in HCA Healthcare by 31.7% during the third quarter. MML Investors Services LLC now owns 17,816 shares of the company’s stock worth $7,241,000 after buying an additional 4,285 shares during the last quarter. Meritage Group LP acquired a new stake in HCA Healthcare during the 3rd quarter valued at $150,548,000. Galvin Gaustad & Stein LLC bought a new stake in shares of HCA Healthcare during the fourth quarter worth $18,044,000. Alpha DNA Investment Management LLC bought a new stake in HCA Healthcare during the 3rd quarter worth about $869,000. Finally, NRI Wealth Management LC bought a new stake in shares of HCA Healthcare during the fourth quarter valued at approximately $2,896,000. 62.73% of the stock is owned by institutional investors.

Analyst Ratings Changes

Several equities research analysts have recently commented on HCA shares. Raymond James cut HCA Healthcare from an “outperform” rating to a “market perform” rating in a research note on Friday, November 22nd. Barclays cut their target price on shares of HCA Healthcare from $392.00 to $366.00 and set an “overweight” rating on the stock in a research report on Monday, January 27th. Royal Bank of Canada reduced their price objective on shares of HCA Healthcare from $405.00 to $384.00 and set an “outperform” rating on the stock in a research note on Monday, January 27th. TD Cowen reduced their price target on HCA Healthcare from $450.00 to $440.00 and set a “buy” rating on the stock in a research report on Monday, October 28th. Finally, Wells Fargo & Company cut HCA Healthcare from an “equal weight” rating to an “underweight” rating and reduced their target price for the stock from $400.00 to $320.00 in a report on Monday, November 25th. One analyst has rated the stock with a sell rating, three have given a hold rating, thirteen have assigned a buy rating and two have assigned a strong buy rating to the company. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of $385.67.

HCA Healthcare Stock Performance

Shares of HCA Healthcare stock opened at $318.28 on Tuesday. The firm has a market cap of $80.62 billion, a price-to-earnings ratio of 14.49, a price-to-earnings-growth ratio of 1.11 and a beta of 1.64. The stock’s 50-day moving average is $313.75 and its 200-day moving average is $353.51. The company has a debt-to-equity ratio of 69.07, a current ratio of 1.08 and a quick ratio of 0.97. HCA Healthcare, Inc. has a one year low of $289.98 and a one year high of $417.14.

HCA Healthcare (NYSE:HCA) last announced its earnings results on Friday, January 24th. The company reported $6.22 EPS for the quarter, topping the consensus estimate of $6.03 by $0.19. HCA Healthcare had a net margin of 8.16% and a return on equity of 586.47%. During the same quarter in the previous year, the business earned $5.90 earnings per share. Equities analysts predict that HCA Healthcare, Inc. will post 24.98 earnings per share for the current fiscal year.

HCA Healthcare Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Monday, March 31st. Investors of record on Monday, March 17th will be paid a $0.72 dividend. The ex-dividend date of this dividend is Monday, March 17th. This is a boost from HCA Healthcare’s previous quarterly dividend of $0.66. This represents a $2.88 annualized dividend and a dividend yield of 0.90%. HCA Healthcare’s dividend payout ratio (DPR) is currently 12.02%.

Insider Buying and Selling at HCA Healthcare

In related news, insider Erol R. Akdamar sold 2,900 shares of HCA Healthcare stock in a transaction dated Thursday, November 14th. The stock was sold at an average price of $353.00, for a total transaction of $1,023,700.00. Following the completion of the transaction, the insider now owns 6,843 shares in the company, valued at approximately $2,415,579. This trade represents a 29.76 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, SVP Phillip G. Billington sold 3,897 shares of the business’s stock in a transaction that occurred on Thursday, November 14th. The stock was sold at an average price of $350.00, for a total value of $1,363,950.00. Following the transaction, the senior vice president now directly owns 52,702 shares in the company, valued at $18,445,700. The trade was a 6.89 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Corporate insiders own 1.60% of the company’s stock.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.